Opportunity Information: Apply for RFA AT 11 001
Apply for RFA AT 11 001
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Mechanistic Research on CAM Natural Products (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213 Research and Training in Complementary and Integrative Health 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.396 Cancer Biology Research.
- This funding opportunity was created on Jun 27, 2012 and posted on Aug 23, 2010.
- Applicants must submit their applications by Mar 1, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $8,100,000.00 to eligible and selected applicants.
- Eligible applicants include: Native American tribal governments (Federally recognized) City or township governments Independent school districts Small businesses Private institutions of higher education State governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education For profit organizations other than small businesses Public housing authorities/Indian housing authorities Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Special district governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The "Mechanistic Research on CAM Natural Products (R01)" funding opportunity (RFA-AT-11-001) is an NIH research grant announcement led by the National Center for Complementary and Alternative Medicine (NCCAM, now known as NCCIH) in partnership with the NIH Office of Dietary Supplements (ODS). Its main goal is to support in-depth, mechanistic studies on promising complementary and alternative medicine (CAM) natural products. The program is built around a straightforward idea: natural products are widely used for health in the United States, but stronger basic and translational evidence is needed to understand what in these products is actually active, what biological targets those active components affect, and what measurable signals (biomarkers or other markers) can indicate beneficial effects, lack of effect, or potential harm. That kind of foundational information is positioned as essential for designing clinical efficacy studies that are truly informative rather than exploratory in a vague way.
Projects responsive to this announcement are expected to go beyond simply showing that a natural product has an effect and instead explain how it works at a molecular, cellular, or systems level. The FOA highlights the importance of identifying active components (for example, specific chemical constituents or fractions), clarifying their molecular and cellular targets, and defining markers that can be used to track biological activity and safety. In addition to classic mechanism-of-action work, the announcement also explicitly welcomes methodological research that improves how natural product constituents are isolated and characterized, as well as how they are measured and confirmed within the original natural matrix (meaning within the complex mixture as it occurs in the plant, extract, or product). This reflects a common challenge in natural products research: the chemistry can be complex, composition can vary by source or processing, and robust analytical methods are often necessary before biological results can be interpreted with confidence.
The award mechanism is the NIH Research Project Grant (R01), which generally supports well-developed research plans that can be carried out by an investigator or team over multiple years. There is no cost sharing or matching requirement stated for applicants. The NIH indicated an estimated total contribution of about $8.1 million to support this initiative. For the first year, the total amount expected to be awarded is approximately $1.625 million in total costs, with an estimated 2 to 4 awards. For years two and three, the total amount expected to be awarded is about $3.25 million per year in total costs, with an estimated 5 to 7 awards each year. As with most NIH opportunities, awards depend on the availability of funds and the quality and merit of the applications received.
Eligibility is broad and includes many types of organizations across the public, private, nonprofit, and academic sectors. Eligible applicants include state, county, city or township governments; federally recognized and other tribal governments and tribal organizations; public and state-controlled and private institutions of higher education; independent school districts; special district governments; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (with the caveat stated in the announcement); and for-profit organizations (including small businesses and other for-profit entities). The FOA also notes eligibility for a range of mission-driven or designated institutions and organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, tribally controlled colleges and universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. It also allows non-U.S. entities (foreign organizations), expanding the potential applicant pool to international groups with relevant expertise.
Administratively, the opportunity was posted on August 23, 2010. The original closing date was November 1, 2012, with a later listed closing date of March 1, 2013, and an archive date of April 1, 2013. The program is categorized under health-related funding activities and is associated with CFDA numbers tied to complementary and integrative health research (93.213) as well as multiple cancer research categories (93.393 through 93.396), signaling that mechanistic natural products work could be relevant across general health and oncology-related domains depending on the specific aims. For full details, NIH provided an additional information link to the official RFA text, and technical assistance contacts are routed through the NIH Office of Extramural Research (OER) webmaster for access or linking issues.
Frequently Asked Questions (FAQs)
What is the "Mechanistic Research on CAM Natural Products (R01)" opportunity?
It is an NIH research grant announcement (RFA-AT-11-001) supporting in-depth, mechanistic studies of promising complementary and alternative medicine (CAM) natural products. The focus is on moving beyond basic observations of effects to explain how a natural product works and how its activity and safety can be measured.
Which NIH organizations are leading or partnering on this funding opportunity?
The announcement is led by the National Center for Complementary and Alternative Medicine (NCCAM, now known as NCCIH) in partnership with the NIH Office of Dietary Supplements (ODS).
What is the main goal of the funding opportunity?
The main goal is to generate stronger basic and translational evidence about CAM natural products by identifying what components are active, what biological targets those components affect, and what measurable markers (such as biomarkers) can indicate benefit, no effect, or potential harm. This foundational work is positioned as essential for designing informative clinical efficacy studies.
What kinds of studies are considered responsive to this FOA?
Projects are expected to go beyond simply demonstrating that a natural product has an effect. Responsive applications should explain mechanisms at a molecular, cellular, or systems level, including identifying active components, clarifying molecular/cellular targets, and defining markers that track biological activity and safety.
Does the FOA require applicants to identify the active components of a natural product?
Yes. The FOA highlights the importance of identifying active components (for example, specific chemical constituents or fractions) as part of understanding how a natural product works.
Does the opportunity emphasize biological targets and mechanisms of action?
Yes. A central expectation is to clarify the molecular and cellular targets of active constituents and to explain mechanism(s) of action rather than stopping at observed outcomes.
What does the FOA say about biomarkers or other markers?
The FOA emphasizes defining measurable signals (biomarkers or other markers) that can indicate beneficial effects, lack of effect, or potential harm, and that can be used to track biological activity and safety.
Are methodological or analytical studies allowed under this announcement?
Yes. In addition to classic mechanism-of-action work, the FOA explicitly welcomes methodological research that improves how natural product constituents are isolated and characterized, and how they are measured and confirmed within the original natural matrix (the complex mixture as it occurs in the plant, extract, or product).
Why does the FOA focus on measurement within the original natural matrix?
The FOA reflects common challenges in natural products research, including complex chemistry and variation in composition by source or processing. Robust analytical methods are often needed so biological results can be interpreted with confidence.
What is the award mechanism for this opportunity?
The award mechanism is the NIH Research Project Grant (R01), which generally supports well-developed research plans conducted by an investigator or a team over multiple years.
Is cost sharing or matching required?
No cost sharing or matching requirement is stated for applicants.
How much funding did NIH estimate for this initiative overall?
The NIH indicated an estimated total contribution of about $8.1 million for the initiative (subject to availability of funds and application quality).
What funding and award numbers were anticipated for the first year?
For the first year, the total amount expected to be awarded was approximately $1.625 million in total costs, with an estimated 2 to 4 awards.
What funding and award numbers were anticipated for years two and three?
For years two and three, the total amount expected to be awarded was about $3.25 million per year in total costs, with an estimated 5 to 7 awards each year.
Are awards guaranteed if an application is submitted?
No. As with most NIH opportunities, awards depend on the availability of funds and the quality and merit of the applications received.
What types of organizations are eligible to apply?
Eligibility is broad and includes many types of organizations across public, private, nonprofit, and academic sectors. Examples listed include state, county, city or township governments; tribal governments and tribal organizations; public and private institutions of higher education; independent school districts; special district governments; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (with a caveat noted in the announcement); and for-profit organizations (including small businesses).
Are specific institution types (such as HBCUs or Hispanic-serving institutions) included in eligibility?
Yes. The FOA notes eligibility for HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, tribally controlled colleges and universities (TCCUs), and other mission-driven or designated institutions and organizations.
Are faith-based or community-based organizations eligible?
Yes. The FOA includes faith-based and community-based organizations among eligible applicant types.
Are U.S. territories or possessions eligible to apply?
Yes. The FOA allows U.S. territories or possessions as eligible applicants.
Are foreign (non-U.S.) organizations eligible?
Yes. The FOA allows non-U.S. entities (foreign organizations), expanding eligibility to international groups with relevant expertise.
When was this funding opportunity posted?
The opportunity was posted on August 23, 2010.
What were the closing and archive dates listed for this opportunity?
The information provided lists an original closing date of November 1, 2012, a later listed closing date of March 1, 2013, and an archive date of April 1, 2013.
What general funding category does this opportunity fall under?
It is categorized under health-related funding activities.
Which CFDA numbers are associated with this opportunity?
The opportunity is associated with CFDA 93.213 (complementary and integrative health research) and multiple cancer research categories (93.393 through 93.396), indicating potential relevance across general health and oncology-related domains depending on the project aims.
Where does NIH direct applicants for official details and the full RFA text?
NIH provided an additional information link to the official RFA text for full details.
Who is listed for technical assistance related to access or linking issues?
Technical assistance contacts are routed through the NIH Office of Extramural Research (OER) webmaster for access or linking issues.
Browse more opportunities from the same category: Health
Next opportunity: ROSES 2010 Living with a Star Targeted Research and Technology
Previous opportunity: AGRICULTURAL INNOVATION IN SOUTHERN SUDAN
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AT 11 001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AT 11 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Clinically Relevant Comparative Effectiveness of Alcoholism Treatments (R01) Apply for PAS 10 273 Funding Number: PAS 10 273 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Service Area Competitions Apply for HRSA 11 007 Funding Number: HRSA 11 007 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competitions Apply for HRSA 11 008 Funding Number: HRSA 11 008 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competitions Apply for HRSA 11 009 Funding Number: HRSA 11 009 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competitions Apply for HRSA 11 010 Funding Number: HRSA 11 010 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Ryan White Part B HIV Care Grant Program Apply for HRSA 11 061 Funding Number: HRSA 11 061 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competitions Apply for HRSA 11 011 Funding Number: HRSA 11 011 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competitions Apply for HRSA 11 012 Funding Number: HRSA 11 012 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competitions Apply for HRSA 11 013 Funding Number: HRSA 11 013 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competitions Apply for HRSA 11 014 Funding Number: HRSA 11 014 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improving Evidence Based Mental Health Screening and Treatment for Persons with Mental Disorders in the Justice System (R34) Apply for RFA MH 11 061 Funding Number: RFA MH 11 061 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Improving Evidence Based Mental Health Screening and Treatment for Persons with Mental Disorders in the Justice System (R01) Apply for RFA MH 11 060 Funding Number: RFA MH 11 060 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Orphans and Vulnerable Children (OVC) Program Apply for USAID ETHIOPIA 663 10 000001 RFA Funding Number: USAID ETHIOPIA 663 10 000001 RFA Agency: Ethiopia USAID Addis Ababa Category: Health Funding Amount: $92,106,320 |
| NIDCR Small Grant Program for New Investigators (R03) Apply for PAR 10 275 Funding Number: PAR 10 275 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Rural Health Network Development Program Apply for HRSA 11 089 Funding Number: HRSA 11 089 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Biomarkers of Alcohol Consumption and Alcohol induced Tissue Injury (STTR R41/R42) Apply for RFA AA 11 005 Funding Number: RFA AA 11 005 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Biomarkers of Alcohol Consumption and Alcohol induced Tissue Injury (SBIR R43/R44) Apply for RFA AA 11 004 Funding Number: RFA AA 11 004 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| MCH Research Apply for HRSA 11 016 Funding Number: HRSA 11 016 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Modeling the Scientific Workforce (U01) Apply for RFA GM 11 007 Funding Number: RFA GM 11 007 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Revolutionary Genome Sequencing Technologies The 1000 Genome (R01) Apply for RFA HG 10 012 Funding Number: RFA HG 10 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AT 11 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
